Literature DB >> 11045902

Pharmacophore/receptor models for GABA(A)/BzR alpha2beta3gamma2, alpha3beta3gamma2 and alpha4beta3gamma2 recombinant subtypes. Included volume analysis and comparison to alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2 subtypes.

X He1, Q Huang, C Ma, S Yu, R McKernan, J M Cook.   

Abstract

Pharmacophore/receptor models for 6 recombinant GABA(A)/BzR subtypes (alphax beta3gamma2, x = 1-6) have been established via an SAR ligand mapping approach. This study was based on the affinities of 166 BzR ligands at 6 distinct (alpha1-6beta3gamma2) recombinant GABA(A)/BzR receptor subtypes from at least twelve different structural families. Examination of the included volumes indicated that the shapes of binding pockets for alpha1, alpha2 and alpha3 subtypes are very similar to each other. Region L2 for the alpha5 containing subtype appeared to be larger in size than the analogous region of the other receptor subtypes. Region L(Di), in contrast, appeared to be larger in the alpha1 subtype than in the other subtypes. Moreover, region L3 in the alpha6 subtype is either very small or nonexistent in this diazepam insensitive "DI" subtype as compared to the other subtypes. Preliminary results for the alpha4-containing receptor subtype (DI) indicate that L3 in the alpha4 subtype suffers a similar fate. Use of the pharmacophore/receptor models for these subtypes have resulted in the design of novel BzR ligands selective for the alpha5beta3gamma2, receptor subtype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045902

Source DB:  PubMed          Journal:  Drug Des Discov        ISSN: 1026-7921


  9 in total

1.  Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma.

Authors:  Christopher S Hackett; David A Quigley; Robyn A Wong; Justin Chen; Christine Cheng; Young K Song; Jun S Wei; Ludmila Pawlikowska; Yun Bao; David D Goldenberg; Kim Nguyen; W Clay Gustafson; Sundari K Rallapalli; Yoon-Jae Cho; James M Cook; Serguei Kozlov; Jian-Hua Mao; Terry Van Dyke; Pui-Yan Kwok; Javed Khan; Allan Balmain; QiWen Fan; William A Weiss
Journal:  Cell Rep       Date:  2014-10-23       Impact factor: 9.423

2.  Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.

Authors:  Wenyuan Yin; Samarpan Majumder; Terry Clayton; Steven Petrou; Michael L VanLinn; Ojas A Namjoshi; Chunrong Ma; Brett A Cromer; Bryan L Roth; Donna M Platt; James M Cook
Journal:  Bioorg Med Chem       Date:  2010-09-29       Impact factor: 3.641

3.  Effects of the benzodiazepine GABAA α1-preferring antagonist 3-isopropoxy-β-carboline hydrochloride (3-ISOPBC) on alcohol seeking and self-administration in baboons.

Authors:  August F Holtyn; V V N Phani Babu Tiruveedhula; Michael Rajesh Stephen; James M Cook; Elise M Weerts
Journal:  Drug Alcohol Depend       Date:  2016-11-04       Impact factor: 4.492

4.  Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.

Authors:  Zdravko Varagic; Joachim Ramerstorfer; Shengming Huang; Sundari Rallapalli; Isabella Sarto-Jackson; James Cook; Werner Sieghart; Margot Ernst
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

5.  Docking of 1,4-benzodiazepines in the alpha1/gamma2 GABA(A) receptor modulator site.

Authors:  D Berezhnoy; T T Gibbs; D H Farb
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

Review 6.  A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model.

Authors:  Terry Clayton; Michael M Poe; Sundari Rallapalli; Poonam Biawat; Miroslav M Savić; James K Rowlett; George Gallos; Charles W Emala; Catherine C Kaczorowski; Douglas C Stafford; Leggy A Arnold; James M Cook
Journal:  Int J Med Chem       Date:  2015-11-10

7.  Non-sedating benzodiazepines cause paralysis and tissue damage in the parasitic blood fluke Schistosoma mansoni.

Authors:  Paul McCusker; Md Yeunus Mian; Guanguan Li; Michael D Olp; V V N Phani Babu Tiruveedhula; Farjana Rashid; Lalit Kumar Golani; Ranjit S Verma; Brian C Smith; James M Cook; John D Chan
Journal:  PLoS Negl Trop Dis       Date:  2019-11-15

Review 8.  Exploiting the Indole Scaffold to Design Compounds Binding to Different Pharmacological Targets.

Authors:  Sabrina Taliani; Federico Da Settimo; Claudia Martini; Sonia Laneri; Ettore Novellino; Giovanni Greco
Journal:  Molecules       Date:  2020-05-16       Impact factor: 4.411

9.  A unified model of the GABA(A) receptor comprising agonist and benzodiazepine binding sites.

Authors:  Rikke Bergmann; Kristine Kongsbak; Pernille Louise Sørensen; Tommy Sander; Thomas Balle
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.